Verve Therapeutics
Lisa Kasiewicz is an associate principal scientist, and formulation at Verve Therapeutics with expertise in RNAi, gene therapy, and lipid nanoparticle nucleic acid delivery technology. She received her Ph.D. in chemical engineering from Carnegie Mellon University, where her research into diabetic wound healing transitioned into how nanoparticle design can enhance delivery to or avoid interaction with the immune system. Dr. Kasiewicz received her B.S. in chemical engineering from Columbia University.
This person is not in any teams
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.